Treatment of depression may increase tinnitus

Tinnitus, which manifests itself as a constant ringing or humming in the ears in the absence of an external sound source, affects up to 14% of the world’s population and is often accompanied by severe forms of anxiety disorders. For a long time, the relationship between mental health and the severity of tinnitus has been a subject of debate, but recent findings suggest a direct correlation between these processes and the concentration of the neurotransmitter serotonin. It has been established that an excess of serotonin in specific areas of the brain can activate auditory circuits, making the symptoms of tinnitus more pronounced and distressing for patients.

The experimental verification of this hypothesis became possible thanks to the use of optogenetics methods. Using fiber-optic systems, light pulses were sent to the brain, which selectively activated the neurons responsible for the production of serotonin. The results showed that this stimulation not only excited the emotional centers, but also directly stimulated the auditory apparatus of the brain. The test subjects exhibited behavioral responses that were identical to the symptoms of tinnitus in humans, confirming the existence of a direct functional link between the release of neurotransmitters and the distortion of sound perception.

This discovery is particularly relevant for patients who take selective serotonin reuptake inhibitors (SSRIs), a common class of antidepressants. These medications artificially maintain high levels of serotonin to combat depression and anxiety. However, in practice, this often leads to a paradoxical effect: as patients’ overall mental well-being improves, they may experience an increase in tinnitus. Thus, the mechanism intended to alleviate suffering becomes a trigger for a new source of discomfort.

Doctors and scientists point out the need to maintain a balance in the selection of therapeutic schemes. It is important for clinicians to recognize complaints of impaired hearing as a direct consequence of pharmacotherapy, rather than a mere coincidence or progression of the disease, in a timely manner. The collaborative work of the doctor and the patient in selecting a treatment regimen should be aimed at minimizing the side effects on the auditory system while maintaining sufficient antidepressant effects.

Further research is focused on the development of targeted drugs that can selectively affect the serotonin system. The main goal is to increase the level of neurotransmitter only in those areas of the brain that are responsible for the emotional background, without affecting the auditory pathways. The creation of such drugs with regional or cellular specificity will allow millions of people to effectively treat mental disorders without the risk of developing or exacerbating tinnitus.